| Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer V Espeli, E Zucca, M Ghielmini, O Giannini, A Salatino, F Martucci, ... Oral oncology 48 (3), 266-271, 2012 | 108 | 2012 |
| Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma AF Hottinger, AB Aissa, V Espeli, D Squiban, N Dunkel, MI Vargas, ... British journal of cancer 110 (11), 2655-2661, 2014 | 64 | 2014 |
| Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma AF Hottinger, AB Aissa, V Espeli, D Squiban, N Dunkel, MI Vargas, ... British journal of cancer 110 (11), 2655-2661, 2014 | 64 | 2014 |
| Factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas: development and external validation of a predictive nomogram A Maurichi, R Miceli, H Eriksson, J Newton-Bishop, J Nsengimana, ... Journal of Clinical Oncology 38 (14), 1591, 2020 | 62 | 2020 |
| Immunotherapies and future combination strategies for head and neck squamous cell carcinoma V Cristina, RG Herrera-Gómez, P Szturz, V Espeli, M Siano International journal of molecular sciences 20 (21), 5399, 2019 | 43 | 2019 |
| Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland E Lerch, V Espeli, E Zucca, L Leoncini, G Scali, O Mora, A Bordoni, ... Tumori Journal 95 (3), 303-310, 2009 | 38 | 2009 |
| Vertebral body stent augmentation to reconstruct the anterior column in neoplastic extreme osteolysis A Cianfoni, D Distefano, E Pravatà, V Espeli, G Pesce, P Mordasini, ... Journal of neurointerventional surgery 11 (3), 313-318, 2019 | 26 | 2019 |
| Multicenter phase II study of panitumumab in platinum pretreated, advanced head and neck squamous cell cancer M Siano, F Molinari, V Martin, N Mach, M Früh, S Freguia, I Corradino, ... The oncologist 22 (7), 782-e70, 2017 | 25 | 2017 |
| Moving beyond the friend-foe myth: a scoping review of the use of social media in adolescent and young adult oncology E De Clercq, M Rost, F Gumy-Pause, T Diesch, V Espeli, BS Elger Journal of adolescent and young adult oncology 9 (5), 561-571, 2020 | 24 | 2020 |
| Safety and preliminary efficacy of talimogene laherparepvec (T-VEC) in combination (combo) with pembrobrolizumab (Pembro) in patients (pts) with recurrent or metastatic … KJ Harrington, AH Kong, N Mach, T Rordorf, J Corral Jaime, V Espeli, ... Journal of Clinical Oncology 36 (15_suppl), 6036-6036, 2018 | 24 | 2018 |
| Stent screw–assisted internal fixation (SAIF): clinical report of a novel approach to stabilizing and internally fixating vertebrae destroyed by malignancy A Cianfoni, D Distefano, P Scarone, GA Pesce, V Espeli, L La Barbera, ... Journal of Neurosurgery: Spine 32 (4), 507-518, 2019 | 21 | 2019 |
| Cost-effectiveness of nivolumab in the treatment of head and neck cancer A Hirschmann, JE Lupatsch, M Schwenkglenks, CM Panje, ... Oral oncology 87, 104-110, 2018 | 20 | 2018 |
| Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery MA Broglie, SJ Stoeckli, R Sauter, P Pasche, A Reinhard, L de Leval, ... Head & neck 39 (10), 2004-2015, 2017 | 20 | 2017 |
| Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial M Siano, V Espeli, N Mach, P Bossi, L Licitra, M Ghielmini, M Frattini, ... Oral oncology 82, 144-151, 2018 | 15 | 2018 |
| Paranasal sinus metastasis of breast cancer P Pittoni, S Di Lascio, M Conti-Beltraminelli, MC Valli, V Espeli, ... Case Reports 2014, bcr2014205171, 2014 | 15 | 2014 |
| Immune-related acute and lymphocytic gastritis in a patient with metastatic melanoma treated with pembrolizumab immunotherapy P Gaffuri, V Espeli, F Fulciniti, G Paone, M Bergmann Pathologica 111 (3), 92, 2019 | 14 | 2019 |
| Diagnostic accuracy of PET/CT or PET/MRI using PSMA-targeting radiopharmaceuticals in high-grade gliomas: a systematic review and a bivariate meta-analysis B Muoio, D Albano, F Dondi, F Bertagna, V Garibotto, J Kunikowska, ... Diagnostics 12 (7), 1665, 2022 | 12 | 2022 |
| Weekly multi-agent chemotherapy (CMF-b) for advanced non-melanoma skin cancer V Espeli, E Ruegg, AF Hottinger, A Modarressi, PY Dietrich Anticancer research 36 (5), 2359-2364, 2016 | 9 | 2016 |
| Early safety from phase 1b/3, multicenter, open-label, randomized trial of talimogene laherparepvec (T-VEC)+ pembrolizumab (pembro) for recurrent or metastatic squamous cell … K Harrington, A Kong, N Mach, T Rordorf, J Corral, V Espeli, S Treichel, ... Annals of Oncology 28, v394, 2017 | 8 | 2017 |
| Covid-19 and beyond: Broadening horizons about social media use in oncology. A survey study with healthcare professionals caring for youth with cancer M Rost, V Espeli, M Ansari, N von der Weid, BS Elger, E De Clercq Health policy and technology 11 (3), 100610, 2022 | 7 | 2022 |
